ArticleFrontiers in medicine2025
Clinical characteristics, clinical laboratories, and risk factors of elderly patients with chronic obstructive pulmonary disease complicated with pulmonary embolism.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The objective of this research is to examine the occurrence, clinical manifestations, and determinants of pulmonary embolism (PE) in older individuals diagnosed with chronic obstructive pulmonary disease (COPD). Methods: A retrospective analysis was performed on elderly patients diagnosed with COPD, who were admitted to five different hospitals within our province. These patients were categorized into two groups based on the presence or absence of pulmonary embolism (PE). And systematically compile and examine the foundational data, clinical attributes, and pertinent laboratory parameters outlined in their respective medical records. These encompass blood routine, arterial blood gas analysis, coagulation markers, and biochemical indicators. Results: A total of 958 elderly patients with COPD were included in the study. Among them, 121 patients (12.63%) were found to have complications with PE. During hospitalization, 50 cases (5.22%) resulted in death. In the multivariate analysis, several factors were found to be significantly associated with a higher prevalence of PE, including age, female gender, deep vein thrombosis, hypertension, PaCO Conclusion: It is essential to give careful attention to the prevalence and factors that put elderly patients with COPD at risk for PE. The utilization of RDW could potentially serve as a predictive tool for identifying the onset of PE in COPD patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.